- Home
- GDHG vs BDRX Comparison
GDHG vs BDRX Comparison
Compare GDHG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDHG | BDRX |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 4.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDHG | BDRX |
|---|---|---|
| Price | $1.88 | $2.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 2.8M |
| Earning Date | 07-11-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,666,899.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.83 | $2.22 |
| 52 Week High | $1,968.41 | $92.00 |
Technical Indicators
Market Signals| Indicator | GDHG | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 21.02 | 38.94 |
| Support Level | $1.83 | $2.22 |
| Resistance Level | $2.75 | $7.22 |
| Average True Range (ATR) | 0.19 | 0.71 |
| MACD | -0.04 | -0.22 |
| Stochastic Oscillator | 3.99 | 4.60 |
Price Performance
Historical ComparisonAbout GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.